Find and Pitch Jounalists, Get Your Story Covered

Tags: Science Nature Podcast 2024 Computer science Machine learning

	Profile	Recent Articles on Subject
1	Wayne Kuznar MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Using Immune Biomarkers to Guide Treatment in TNBC - 23 days ago
2	Amir Ali, PharmD, BCOP Pharmacy Times Clinical Hem/Onc Pharmacist. USC Assistant Professor. Founder of OncologySolutionsRx. Los Angeles, CA Healthcareoncologypharmacyeducation	Emerging BCMA-Directed Therapies in Multiple Myeloma: Bispecific Antibodies and CAR T-Cell Therapies - 27 days ago
3	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Advances in ALL at ASH Meeting Include New Blinatumomab Data and More - about 1 month ago Pirtobrutinib Shows Potential in Heavily Pretreated Follicular Lymphoma - about 1 year ago Novel Combination Active in Large B-Cell Lymphoma, Even After CAR-T - about 1 year ago Axi-Cel Shows Durable Responses, Prolongs Overall Survival in Older LBCL Patients - about 1 year ago Liso-Cel a Potential New CAR-T Option for High-Risk R/R Follicular Lymphoma - about 1 year ago Tisa-Cel Yields Durable Responses in R/R Follicular Lymphoma - about 1 year ago Responses to Mosunetuzumab in Follicular Lymphoma Remain Durable at 3 Years - about 1 year ago Positive Results for Odronextamab in Relapsed/Refractory DLBCL - about 1 year ago
4	Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. journalismhealthcancer researchSTAT News	STAT+: For a leukemia that keeps returning, AbbVie drug may offer chance for a deep remission - about 1 month ago
5	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	SABCS 2024: Harnessing the Power of Tumor-Infiltrating Lymphocytes to Revolutionize Breast Cancer Treatment - about 1 month ago New Strategies in SCLC and DLBCL Are Transforming the Treatment Landscape - about 2 months ago
6	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Cellenkos presents promising phase 1b data for CK0804 in myelofibrosis - about 1 month ago Scottish medicines consortium approves CAR T-cell therapy for blood cancer - 2 months ago
7	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	Novel BTK Inhibitor Succeeds in Heavily Pretreated Immune Thrombocytopenia - about 1 month ago Dual Targeted CAR-T Yields 99% Response Rate in Pediatric ALL - about 2 months ago FDA Approves First CAR-T for Chronic Lymphocytic Leukemia - 10 months ago JAK1 Inhibitor Shows 'Remarkable' Activity in T-Cell Lymphoma - about 1 year ago Non-Covalent BTK Inhibitor Approved for CLL - about 1 year ago
8	Danielle Gerhard, PhD The Scientist Assistant Editor @TheScientistLLC. United Kingdom scienceediting	A Tissue-Sized Cell with Billions of Nuclei  - about 2 months ago
9	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Advances in CAR T-Cell Therapy and Bispecifics for Relapsed/Refractory Multiple Myeloma - 3 months ago
10	Shelby Bradford, PhD The Scientist Assistant Editor @TheScientistLLC. Opinions my own. scienceediting	Innate Immune Cells Develop Memory with a T Cell Marker - 4 months ago

Journalists covering b cell